SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'InterestReceivedDirect' RNUGF (ReNeuron Group) Interest Received
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Interest Received

ReNeuron Group (ReNeuron Group) Interest Received


View and export this data going back to 2006. Start your Free Trial

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

ReNeuron Group (ReNeuron Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Interest Received
Comparable Companies
LSE:PYC LSE:NFX LSE:EVG LSE:APTA LSE:FAB LSE:IXI LSE:GENF LSE:OCTP LSE:VAL AQSE:INC OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
RENE.GB:UK RENE:UK RQE1:Germany
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
Website
https://www.reneuron.com
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.